Orca Bio logo

Orca Bio Funding & Investors

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.

orcabio.com

Total Amount Raised: $192,000,000

Orca Bio Funding Rounds

  • Series D

    $192,000,000

    Series D Investors

    Blue Chip Venture Company
    Kaiser Permanente
    IMRF
    8VC
    +ND Capital
    Lightspeed Venture Partners
    Dream Variation Ventures
    Felicis Ventures
    Mubadala
    Kaiser Family Foundation
    DCVC Bio
Funding info provided by Diffbot.